发明名称 |
Compositions comprising biomembrane sealing agent for treatment of neuronal injury, and methods of use |
摘要 |
The invention provides compositions, kits, and methods for treatment of neuronal injury. In one embodiment, the composition comprises a biomembrane sealing agent, such as PEG, and a bioactive agent, such as a magnesium compound. The biomembrane sealing agent and/or the bioactive agent an intravenous administration, an intramuscular administration, an intrathecal administration, a subcutaneous administration, an epidural administration, a parenteral administration, a direct application onto or adjacent to a site of the pathological condition, and any combinations thereof. Alternatively, the biomembrane sealing agent and/or the bioactive agent may be delivered from a pump or an implant. |
申请公布号 |
US8945623(B2) |
申请公布日期 |
2015.02.03 |
申请号 |
US200611418152 |
申请日期 |
2006.05.03 |
申请人 |
Warsaw Orthopedic, Inc. |
发明人 |
Roy Josee;McKay William F.;Marx Jeffrey C. |
分类号 |
A61K38/20;A61K38/18;A61K38/11;A61K38/05;A61K31/65;A61K31/56;A61K9/14;A61K9/00;A61K33/06;A61K47/10 |
主分类号 |
A61K38/20 |
代理机构 |
Sorell, Lenna & Schmidt LLP |
代理人 |
Schmidt William D.;Sorell, Lenna & Schmidt LLP |
主权项 |
1. An intravenous pharmaceutical composition for treating a neuronal injury comprising a therapeutically effective amount of a biomembrane sealing agent comprising between 20 and 50% w/w of polyethylene glycol and at least one magnesium compound, wherein the polyethylene glycol comprises PEG 3350. |
地址 |
Warsaw IN US |